Abstract
The North American Pediatric Renal Transplant Cooperative Study collects extensive data on all transplants entered into its registry. For this study we evaluated 568 cadaver kidney and 492 live-donor recipients with graft function at 30 days post transplant. Utilizing maintenance immunosuppressive therapy at 30 days post transplant we evaluated patient and graft outcome, mortality and morbidity over the first 6 months post transplant. For cadaver kidney recipients, 36 patients were receiving prednisone and azathioprine (PA), 114 were maintained on prednisone and cyclosporine (PC) and 418 were on prednisone, cyclosporine and azathioprine (PCA). Patients receiving PA had a greater incidence of rejection prior to 30 days, a greater incidence of hospitalization for rejection and for hypertension over the next 6 months and a greater loss of allograft in the first 6 months compared with the other two groups. The only difference noted between PC and PCA was a lower serum creatinine in the PCA group at 6 months. For living-related kidney recipients, there were 78 patients maintained on PA, 97 on PC and 317 on PCA. Again patients receiving PA had a higher rate of hospitalization for rejection and a higher rate of graft loss. When patients receiving PC were compared with those receiving PCA, no differences were noted in the 6-month serum creatinine values, but a greater percentage of PCA patients were receiving antibiotics on day 30. We conclude that PA is poor therapy for both groups, PCA is ideal therapy for cadaver kidney recipients, but no beneficial effects are noted when PCA is used over PC for live-related donor kidney transplants.
Similar content being viewed by others
References
Squifflet JP, Sutherland DJR, Field J, Rynasiewicz JJ, Heil J, Najarian JS (1983) Synergistic immunosuppressive effect of cyclosporine A and azathioprine. Transplant Proc 15: 520
Slapak M, Geoghegan T, Digard N, Ahmed K, Sharman VL, Crockett R (1985) The use of low-dose cyclosporin A in combination with azathioprine and steroids in renal transplantation. Transplant Proc 17: 1222–1225
Fries D, Kechrid C, Charpentier B, Hammouche M, Moulin B (1985) A prospective study of a triple association: cyclosporin, corticosteroids, and azathioprine in immunologically high-risk renal transplantation. Transplant Proc 17: 1231–1234
United States renal disease data system: 1991 report. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, 1991. (NIH publication no. 91-3176.)
McEnery P, Stablein D, Arbus G, Tejani A (1992) Renal Transplantation in Children. New Engl J Med 326: 1727–1732
Calne R, Rolles K, White DJ, Thiru S, McMaster P, Gibby O, Willimas R, Evans DB, Henderson R, Hamilton DL, Boone N (1981) Cyclosporin A in clinical organ grafting. Transplant Proc 13: 349
Simmons RL, Canafax DM, Fryd DS, Ascher NL, Payne WD, Sutherland DER, Najarian JS (1986) New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation. Transplant Proc 18: 76
First MR, Alexander JW, Wadhwa N, Penn I, Munda R, Fidler JP, Weiskittel P (1986) The use of low doses of cyclosporine, azathioprine and prednisolone in renal transplantation. Transplant Proc 18: 132
Illner WD, Land W, Haberstzer R, Hillebrand G, Scheibner ST, Castro LA, Laible V, Schnabl G (1985) Cyclosporine in combination with azathioprine and steroids in cadaveric renal transplantation. Transplant Proc 17: 1181
The 1989 Report of the North American Pediatric Renal Transplant Cooperative Study (1990) Pediatr Nephrol 4: 542–553
European Multicentre Trial Group (1983) Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial. Lancet II: 986
The Canadian Multicentre Transplant Study Group (1983) A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 309: 809
Starzl TE, Weil R, Keel R, Iwatsuki S, Klintmalm G, Schroter GPJ, Iwaki Y, Terasaki PI, Porter KA (1980) The use of cyclosporin A and prednisone in cadaveric transplantation. Surg Gynecol Obstet 151: 17
Kahan BD, VanBuren C, Flechner S, Payne WD, Boileau M, Kerman R (1983) Cyclosporine immunosuppression mitigates immunologic risk factors in renal allotransplantation. Transplant Proc 15: 2469
Ponticelli C, Minetti L, Quarto de Palo F, Vegeto A, Belli L, Corbetta G, DeVecchi A, Civati G, Vazzola A (1986) Controlled trial of cyclosporine in cadaveric renal transplantation: a two-year follow-up. Transplant Proc 18: 1246
Ponticelli C, Tarantino A, Montagnino G, Arnoldi A, Banfi G, DeVecchi A, Zubani R, Berardinelli L, Vegeto A (1988) A randomized trial comparing triple-drug and double-drug therapy in renal transplantation. Transplantation 45: 913–918
Brinker KR, Dickerman RM, Gonwa TA, Hull AR, Langley JW, Long DL, Nesser DA, Trevino G, Velez RI, Vergne-Marini PJ (1990) A randomized trial comparing double-drug and triple-drug therapy in primary cadaveric renal transplants. Transplantation 50: 43–49
Isoniemi H, Eklund B, Hockerstedt K, Korsback C, Salmel K, Willebrand EV, Hayry P, Ahonen J (1990) Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results. Transplant Proc 22: 1365–1366
Salaman JR, Griffin PJA, Ross WB, Williams JD (1987) A controlled trial of triple therapy in renal transplantation. Transplant Proc 19: 1935–1936
Slapak M (1987) Triple and quadruple immunosuppressive therapy in organ transplantation. Wickham Conference. Lancet II: 958–960
Predictive factors of sustained growth post transplant in renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (1991) Pediatr Res 29: 353A
Curtis JJ (1991) Distinguishing the causes of post-transplant hypertension. Pediatr Nephrol 5: 108–111
Wilkinson AH, Smith JL, Hunsicker LG, Tobacman J, Kapelanski DP, Johnson M, Wright FH, Behrendt PM, Corry RJ (1989) Increased frequency of post-transplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 47: 293–296
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tejani, A., Stablein, D., Fine, R. et al. Maintenance immunosuppression therapy and outcome of renal transplantation in North American children — a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 7, 132–137 (1993). https://doi.org/10.1007/BF00864375
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00864375